Document is current
Any future updates will be listed below
-
Authors
De Francisci, Mattia https://orcid.org/0000-0001-5137-2697
Silvestri, Erica https://orcid.org/0000-0002-1853-0777
Bettinelli, Andrea https://orcid.org/0000-0002-3539-3540
Volpi, Tommaso https://orcid.org/0000-0002-5451-6710
Goyal, Manu S. https://orcid.org/0000-0003-1970-4270
Vlassenko, Andrei G.
Cecchin, Diego https://orcid.org/0000-0001-7956-1924
Bertoldo, Alessandra https://orcid.org/0000-0002-6262-6354
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01AG053503, R01AG057536, RF1AG073210)
- License Information
-
More Information
Article History
Received: 16 June 2024
Accepted: 21 November 2024
First Online: 24 December 2024
Declarations
:
: All assessments and imaging procedures were approved by Human Research Protection Office and Radioactive Drug Research Committee at Washington University in St. Louis (healthy controls). Concerning glioma patients, the protocol has been approved by the local Ethics Committee of the University Hospital of Padova. All procedures performed in studies were conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.
: Informed written consent was obtained from all individual participants included in the study.
: Participants signed informed consent regarding publishing their data.
: The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
